Can treatment of pediatric Hodgkin's lymphoma be improved by PET imaging and proton therapy?

Strahlentherapie und Onkologie

Volumn 189, Issue 1, 2013, Pages 54-61

  Knausl B ^a   Lutgendorf Caucig C ^a   Hopfgartner, J ^a   Dieckmann, K ^a   Kurch, L ^b   Pelz, T ^c   Potter R ^a   Georg, D ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Intensit tsmodulation; Langzeitnebenwirkungen; Positronenemissionstomographie Computertomographie; Protonen; Schl sselw rter: M. Hodgkin im Kindesalter

Indexed keywords

ARTICLE; CANCER STAGING; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HEART; HODGKIN DISEASE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PROTON THERAPY; RADIATION DOSE; THYROID GLAND;

BONE AND BONES; BREAST; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; HEART; HODGKIN DISEASE; HUMANS; LUNG; LYMPHATIC METASTASIS; NEOADJUVANT THERAPY; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROTON THERAPY; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; RISK FACTORS; THYROID GLAND;

EID: 84871787687     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-012-0235-8     Document Type: Article

References (54)

1. Allard A, Haddy N, Le Deley M et al (2010) Role of radiation dose in the risk of secondary leukemia after a solid tumor in childhood treated between 1980 and 1999. Int J Radiat Oncol Biol Phys 78:1474-1482
2. Andolino D, Hoene T, Xiao L et al (2011) Dosimetric comparison of involved-field three-dimensional conformal photon radiotherapy and breast-sparing proton therapy for the treatment of hodgkin's lymphoma in female paediatric patients. Int J Radiat Oncol Biol Phys 81:e667-e671
3. Bhatia S, Yasui Y, Robison LL et al (2003) High risk of subsequent neoplasms continues with extended follow-up of childhood hodgkin's disease: report from the late effects study group. J Clinl Oncol 21:4386-4394
4. Bhatti P, Veiga L, Ronckers C et al (2010) Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res 174:741-752
5. Bölling T, Kreuziger DC, Ernst I et al (2011) Retrospective, Monocentric Analysis of Late Effects after Total Body Irradiation (TBI) in Adults. Strahlenther Onkol 187:311-315
6. Bölling T, Könemann S, Ernst I, Willich N (2008) Late effects of thoracic irradiation in children. Strahlenther Onkol 184:289-295
7. Brenner D, Hall E (2008) Secondary neutrons in clinical proton radiotherapy: a charged issue. Radiother Oncol 86:165-170
8. Chapet O, Kong F, Quint LE et al (2005) CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan. Int J Radiat Oncol Biol Phys 63:170-178
9. Dasu A, Toma-Dasu I, Olofsson J, Karlsson M (2005) The use of risk estimation models for the induction of secondary cancers following radiotherapy. Acta Oncol 44:339-347
10. Dieckmann K, Widder J, Pötter R (2002) Long-term side effects of radiotherapy in survivors of childhood cancer. Front Radiat Ther Oncol 37:57-68
11. Dörr W, Herrmann T (2002) Cancer induction by radiotherapy: dose dependence and spatial relationship to irradiated volume. I Radiol Prot 22:A117-A121
12. Dörr W, Herrmann T (2002) Second primary tumors after radiotherapy for malignancies. Strahlenther Onkol 178:357-362
13. Dores G, Metayer C, Curtis R et al (2002) Second malignant neoplasms among long-term survivors of hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 20:3484-3494
14. Fotina I, Lütgendorf-Caucig C, Stock M et al (2012) Critical discussion of evaluation parameters for inter observer variability in target definition for radiation therapy. Strahlenther Onkol 188:160-167
15. Furth C, Steffen IG, Amthauer H et al (2009) Early and late therapy response assessment with [18f]fluorodeoxyglucose positron emission tomography in pediatric hodgkin's lymphoma: analysis of a prospective multicenter trial. J Clin Oncol 27:4385-4391
16. GHSG, HD 18 Trial. http://en.ghsg.org/active-trials/articles/hd18-study (27. Aug 2012)
17. Grégoire V, Levendag P, Ang KK et al (2003) CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 69:227-236
18. Hill D, Gilbert E, Dores G et al (2005) Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors. Blood 106:3358-3365
19. Hillbrand M, Georg D, Gadner H et al (2008) Abdominal cancer during early childhood: A dosimetric comparison of proton beams to standard and advanced photon radiotherapy. Radiother Oncol 89:141-149
20. Hillbrand M, Georg D (2010) Assessing a set of optimal user interface parameters for intensity-modulated proton therapy planning. J Appl Clin Med Phys 11:3219
21. Hodgson DC, Hudson MM, Constine LS et al (2007) Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity. Semin Radiat Oncol 17:230-242
22. ICRU Report 78-Prescribing, Recording, and Reporting Proton-Beam Therapy. The International Commission on Radiation Units and Measurements 2007
23. ICRU Report 83-Prescribing, Recording and Reporting Intensity-Modulated- Photon-Beam Therapy (IMRT). The International Commission on Radiation Units and Measurements 2010
24. Hermann T, Baumann M, Dörr W (2006) Klinische Strahlenbiologie. 4th edn, Elsevier, München
25. Kaatsch P, Deblind D, Blettner M, Spix C (2009) Second malignant neoplasms after childhood cancer in germany-results from the long-term follow-up of the German Childhood Cancer Registry. Strahlenther Onkol 185:8-10
26. Kluge R, Körholz D (2011) Role of FDG-PET in Staging and Therapy of Children with Hodgkin Lymphoma. Klin Padiatr 223:315-319
27. Koeck J, Abo-Madyam Y, Lohr F et al (2012) Radiotherapy for early mediastinal Hodgkin Lymphoma: according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy. Int J Radiat Incol Biol Phys 83:268-276
28. Körholz D, Wallace H, Landman-Parker J (2007) EuroNet-PHL-C1: first international Inter-Group Study for classical Hodgkin's lymphoma in children and adolescents
29. Kragl G, Baier F, Lutz S et al (2011) Flattening filter free beams in SBRT and IMRT: dosimetric assessment of peripheral doses. Z Med Phys 21:91-101
30. Kry S, Salehpour M, Followill D et al (2005) The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 62:195-203
31. Lengelé B, Nyssen-behets C, Scalliet P (2007) Anatomical bases for the radiological delineation of lymph node areas. Upper limbs, chest and abdomen. Radiother Oncol 84:335-347
32. Lengelé B, Scalliet P (2009) Anatomical bases for the radiological delineation of lymph node areas. Part III: Pelvis and lower limbs. Radiother Oncol 92:22-33
33. Lorentini S, Amichetti M, Spiazzi L et al (2012) Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma. A comparison with intensity-modulated radiotherapy and a spot size variation assessement. Strahlenther Onkol 188:216-225
34. Lütgendorf-Caugig C, Fotina I, Gallop-Evans E et al (2012) Multi-center evaluation of different target volume delineation concepts in Paediatric Hodgkin Lymphoma (PHL): a case study. Strahlenther Onkol 188:1025-1030
35. MacDonald SM, Trofimov A, Safai S et al (2011) Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes. Int J Radiat Incol Biol Phys 79:121-129
36. Mansur DB, Klein EE, Maserang BP (2007) Measured peripheral dose in pediatric radiation therapy: a comparison of intensity-modulated and conformal techniques. Radiother Oncol 82:179-184
37. Mauz-Koerholz C, Hasenclever D, Dörffel W et al (2010) Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study. J Clin Oncol 28:3680-3686
38. Merchant T (2009) Proton beam therapy in pediatric oncology. Cancer J 15:298-305
39. Müller HL, Gebhardt U, Warmuth-Metz M et al (2012) Meningioma as second malignant neoplasm after oncological treatment during childhood. Strahlenther Onkol 118:438-441
40. Oeffinger K, Mertens A, Sklar C et al (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572-1582
41. Paddick I (2000) A simple scoring ratio to index the conformity of radiosurgical treatment plans. J Neurosurg 93:219-222
42. Paulino AC, Skwarchuk M (2002) Intensity-modulated radiation therapy in the treatment of children. Med Dosim 27:115-120
43. Peeters J, Meitert J, Paulides M et al (2009) Late effects suveillance system after childhoof cancer in germany, austria and parts of switzerland-update 2009. Strahlenther Onkol 185:5-7
44. Poetter R (1999) Paediatric Hodgkin's disease. Eur J Cancer 35:1466-1474
45. Preston DL, Ron E, Tokuoka S et al (2007) Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 168:1-64 (The Radiation Research Society)
46. Schellong G, Riepenhausen M, Bruch C et al (2010) Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies. Pediatr Blood Cancer 55:1145-1152
47. Schneider U, Lomax A, Pemler P et al (2006) The impact of imrt and proton radiotherapy on secondary cancer incidence. Strahlenther Onkol 182:647-652
48. Schneider U, Zwahlen D, Ross D, Kaser-Hotz B (2005) Estimation of radiation-induced cancer from three-dimensional dose distributions: concept of organ equivalent dose. Int J Radiat Oncol Biol Phys 61:1510-1515
49. Schneider U (2009) Mechanistic model of radiation-induced cancer after fractionated radiotherapy using the linear-quadratic formula. Med Phys 36:1138-1143
50. Schneider U, Sumilla M, Robotka J et al (2011) Dose-response relationship for breast cancer induction at radiotherapy dose. Radiat Oncol 6:67
51. Schneider U, Sumila M, Robotka J (2011) Site-specific dose response relationship for cancer induction from combined Japanese A-bomb and Hodgkin cohorts for doses relevant for radiotherapy. Theor Biol Med Model 8:27
52. Slanina J, Heinemann F, Henne K et al (1999) Second malignancies following treatment of Hodgkin's disease: the Freiburg patients 1940-1991. Strahlenther Onkol 175:154-161
53. Timmermann B (2010) Proton beam therapy for childhood malignancies: status report. Klin Padiatr 222:127-133
54. Welte B, Suhr P, Bottke D et al (2010) Second mailgnancies in high-dose areas of previous tumor radiotherapy. Strahlenther Onkol 186:174-179